DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Stintzing S. et al.
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306.

Ann Oncol 2012;
23: 1693-1699

Download Bibliographical Data

Search in:
Access: